Biotech News
-
StageZero Life Sciences Announces Q1 2021 Financial Results and Operational Update
May 17, 2021 (Source) — StageZero Life Sciences, Ltd. (TSX:SZLS) (“StageZero” or the “Company”), a specialist in PCR testing…
-
Valeo Pharma Joins Innovative Medecines Canada
May 17, 2021 (Source) — Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo” or the “Company”),…
-
XPhyto Provides Update on Drug Formulation and Development Business
May 13, 2021 (Source) — Rotigotine transdermal human pilot study successfully completed; program advancing to pivotal study Land…
-
StageZero to Issue Q1 2021 Financial Results and Hold Conference Call on Monday, May 17
May 12, 2021 (Source) — StageZero Life Sciences (“StageZero” or the “Company”) (TSX:SZLS) today announced that it will release…
-
Rritual Superfoods Initiates Canadian Retail Growth Strategy Signing with Ultimate Sales Canada
May 11, 2021 (Source) – Ultimate to Accelerate Rritual’s National Strategy and Rollout Rritual Superfoods Inc. (“Rritual” or the “Company”) (CSE: RSF) (FSE: 0RW) is…
-
StageZero Life Sciences Announces Rexall as Retailer for COVID-19 Saliva Test Kits Throughout Canada
May 11, 2021 (Source) – StageZero Life Sciences, Ltd. (TSX:SZLS) (“StageZero” or the “Company”), a specialist in PCR…
-
Hemostemix Announces Closing of Unit Private Placement
May 10, 2021 (Source) – Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (“Hemostemix” or the “Company”) announces it has closed its…
-
XPhyto Establishes Proof of Concept Station for Point-of-Care 25-minute COVID-19 PCR Test in Germany
May 7, 2021 (Source) — Pilot project includes point-of-care sample collection, PCR processing and final testing of workflow…
-
Hemostemix Announces Warrant Repricing and Extension
May 6, 2021 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (FSE: 2VFO) (“Hemostemix” or the “Company”) is…
-
Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of Product Licenses for MultiXThin Radiographic Barium Contrast
May 5, 2021 (Source) — Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the “Company” or “Voyageur”) is pleased to announce that it…
